sortieren
Medicine and Dentistry
Diseases
100%
Lung Cancer
95%
Symptomatic Treatment
93%
Non Small Cell Lung Cancer
87%
Pleura Mesothelioma
77%
Mesothelioma
72%
Malignant Pleural Effusion
70%
Dyspnea
62%
Lung
57%
Epidermal Growth Factor Receptor
52%
Neoplasm
51%
Interstitial Lung Disease
49%
Infection
49%
Rheumatoid Arthritis
46%
Inflammatory Arthritis
46%
Chronic Lung Disease
46%
Severe Acute Respiratory Syndrome Coronavirus 2
46%
Respiratory Medicine
46%
Cachexia
46%
Bronchoscopy
40%
Overall Survival
40%
Advanced Cancer
36%
Malignant Neoplasm
35%
COVID-19
35%
Oncology
34%
Radiation Therapy
34%
Immunotherapy
31%
Programmed Death-Ligand 1
29%
C Reactive Protein
29%
Biological Marker
29%
Effusion
28%
Droplet Digital Polymerase Chain Reaction
27%
Small Cell Lung Cancer
26%
Jet Ventilation
26%
Treatment Option
25%
Idiopathic Pulmonary Fibrosis
23%
Cohort Effect
23%
Lymph Duct
23%
Computer Assisted Tomography
23%
Non-Small Cell Lung Cancer
23%
Systemic Scleroderma
23%
Vascular Bundle
23%
Procalcitonin
23%
Bacterial Infection
23%
Video-Assisted Thoracoscopic Surgery
23%
Lobectomy
23%
Tumor Cell
23%
Early Diagnosis
23%
Pulmonary Pathology
23%
Odds Ratio
23%
Carcinoembryonic Antigen
23%
Cancer Treatment
23%
Chemoradiotherapy
23%
Durvalumab
23%
Resistance Mutation
23%
Endobronchial Ultrasonography
23%
Transbronchial Aspiration
23%
Randomized Controlled Trial
23%
Sputum
23%
Bone Turnover
23%
Case-Control Study
23%
Early Cancer
23%
Low Density Lipoprotein Cholesterol
23%
Thorax Drainage
20%
Pleura Effusion
20%
Severe Acute Respiratory Syndrome
19%
Adjuvant Therapy
18%
Post-Anesthesia Care Unit
16%
Osimertinib
15%
Thoracentesis
15%
Community-Acquired Pneumonia
15%
Asbestos Exposure
15%
Thorax Pain
15%
Differential Diagnosis
15%
Coughing
15%
Benzodiazepine Derivative
14%
Amino Terminal Sequence
14%
Procollagen
14%
Osteocalcin
14%
Tyrosine-Kinase Inhibitor
14%
Interstitial Lung Disorder
14%
Pneumothorax
14%
Bleeding
14%
Immune Checkpoint Inhibitor
13%
Quality of Life
13%
Progressive Disease
12%
Thoracoscopy
12%
Patient Referral
12%
Clinical Study
11%
Pleural Cavity
11%
Biopsy Technique
11%
Progression Free Survival
11%
Cancer
10%
Aldrete Score
10%
General Anesthesia
9%
Tissue Sampling
9%
Mortality Rate
9%
Tumor Marker
9%
Cancer Staging
9%
Bone Remodeling
8%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
83%
Epidermal Growth Factor Receptor
75%
SARS Coronavirus
70%
Diseases
53%
Malignant Neoplasm
53%
Small Cell Lung Cancer
46%
Infection
43%
Advanced Cancer
41%
Solid Malignant Neoplasm
40%
Lung Cancer
39%
Osimertinib
38%
Clinical Study
38%
Immune Checkpoint Inhibitor
35%
Neoplasm
33%
Overall Survival
32%
Immunotherapy
29%
Progression Free Survival
27%
Antitumor Activity
27%
Biological Marker
26%
Coronavirinae
26%
Cytokine Release Syndrome
25%
Immunopathogenesis
23%
Lorlatinib
23%
Anaplastic Lymphoma Kinase
23%
Immunoglobulin M
23%
Dyspnea
23%
Procalcitonin
23%
Programmed Cell Death
23%
Programmed Death 1 Ligand 1
23%
Durvalumab
23%
Chemoradiation Therapy
23%
Bacterial Infection
23%
Lung Adenocarcinoma
23%
Adverse Event
23%
Enzyme-Linked Immunosorbent Assay
23%
Circulating Tumor DNA
23%
Immunoglobulin M Antibody
23%
COVID-19 Vaccine
23%
Asthma
23%
Prevalence
23%
Chronic Lung Disease
23%
Myocarditis
23%
Protein Tyrosine Kinase Inhibitor
21%
Side Effect
19%
Community Acquired Pneumonia
15%
Disease Exacerbation
12%
Retrospective Study
11%
Pandemic
11%
Decreased Appetite
9%
Severe Acute Respiratory Syndrome
7%
C Reactive Protein
7%
Allergen
6%
Morphine
6%
Immunoglobulin
5%
Midazolam
5%
Death Receptor
5%
CD3 Antigen
5%
Placebo
5%
Immunology and Microbiology
Asthma
76%
Rhinovirus
73%
Infection
60%
Allergen
53%
Inflammatory Arthritis
46%
Immunoglobulin E
37%
Bone Remodeling
37%
Bone Turnover
31%
Amino Terminal Sequence
29%
Immune Checkpoint Inhibitor
27%
Severe Asthma
25%
Enzyme-Linked Immunosorbent Assay
23%
Cholesterol Blood Level
23%
Smelling
23%
Immunotherapy
23%
Pneumonitis
23%
Canis
23%
Antibody Response
23%
Quantitative Reverse Transcription Polymerase Chain Reaction
23%
Durvalumab
23%
Human Respiratory Syncytial Virus
23%
Programmed Death 1 Ligand 1
23%
Programmed Cell Death 1
23%
Osteoblast
15%
Osteoclast
15%
Osteolysis
13%
Nose
11%
CXCL10
11%
Blood Level
11%
Infectious Disease
11%
Body Composition
9%
Muscle
9%
Carboxy Terminal Sequence
8%
Maturation
7%
Gluconeogenesis
7%
Glucose Blood Level
7%
Insulin Resistance
7%
Lipolysis
7%
Lipid Homeostasis
7%
Brown Adipose Tissue
7%
Glucose Homeostasis
7%
Blood Plasma
7%
Systemic Inflammation
7%
Human Rhinovirus A
7%
Bone Development
7%
Peptides
7%
Low-Density Lipoprotein
6%
Asthma Exacerbation
6%
Awareness
5%
Premature Mortality
5%
Sensitization
5%
Virus
5%